Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)

BACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective...

Full description

Bibliographic Details
Main Authors: Akram Saleh, Ayman Hammoudeh, Ramzi Tabbalat, Imadd Al-haddad, Eyass Al-Mousa, Mohammad Jarrah, Mahmoud Izraiq, Assem Nammas, Husham Janabi, Lewa Hazaymeh, Ali Shakhatreh, Youssef Khadder
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2016-01-01
Series:Annals of Saudi Medicine
Online Access:https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17
_version_ 1818483143853735936
author Akram Saleh
Ayman Hammoudeh
Ramzi Tabbalat
Imadd Al-haddad
Eyass Al-Mousa
Mohammad Jarrah
Mahmoud Izraiq
Assem Nammas
Husham Janabi
Lewa Hazaymeh
Ali Shakhatreh
Youssef Khadder
author_facet Akram Saleh
Ayman Hammoudeh
Ramzi Tabbalat
Imadd Al-haddad
Eyass Al-Mousa
Mohammad Jarrah
Mahmoud Izraiq
Assem Nammas
Husham Janabi
Lewa Hazaymeh
Ali Shakhatreh
Youssef Khadder
author_sort Akram Saleh
collection DOAJ
description BACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective multicenter registry of consecutive patients who underwent PCI between January 2013 and February 2014 (JoPCR1). SETTING: 12 tertiary care centers in Amman and Irbid, Jordan. PATIENTS AND METHODS: We collected clinical baseline and follow-up data. MAIN OUTCOME MEASURES: Incidence of stent thrombosis. RESULTS: The mean (standard deviation) age of patients (n=2426) was 59.0 (10.1) years and 20.6% were women. Stents (n=3038) were drug eluting (89.6%), bare metal (9.4%) or bioabsorbable (1.0%). After 1 year, 47 patients (1.97%) had ST, including 44 (94%) definite and 3 (6%) probable ST. Patients who had ST presented with sudden death (n=6; 12.2%) or with a nonfatal event (n=43; 87.8%). Nonfatal events included non-ST-segment elevation acute coronary syndrome (26; 53%), acute ST segment elevation myocardial infarction (n=15; 31%) or heart failure (n=2; 4.1%). ST was associated with significantly higher one-month (22.0% vs. 0.7%) and one-year (12.3% vs. 0.73%) mortality rates compared with patients who did not have ST (P<;.001). ST patients were younger (mean age 52.9 years vs. 58.4 years), had heart failure (64% vs. 18%), left ventricular ejection fraction (LVEF) <45% (36% vs. 13%), ST-segment deviation (70% vs. 48%), and elevated cardiac biomarkers blood levels (62% vs. 40%). In the multivariate analysis, the only factor that was significantly associated with ST was the heart failure (OR = 3.5, 95% confidence interval: 1.8, 6.6; P<.0001). CONCLUSIONS: The incidence of ST was not different from that in other regions and was associated with an increased one-year mortality. Younger age, heart failure, low LVEF, ST-segment deviation, and elevated blood levels of cardiac biomarkers were predictors of ST. LIMITATIONS: Possible selection bias, recall bias, and missing or incomplete information. The majority of patients were lost to follow up after the 6th month. The registry may not fully represent PCI practice and outcome in all areas in the country or region.
first_indexed 2024-12-10T11:56:27Z
format Article
id doaj.art-90c55459f0644dba81d61e4bb514b369
institution Directory Open Access Journal
issn 0256-4947
0975-4466
language English
last_indexed 2024-12-10T11:56:27Z
publishDate 2016-01-01
publisher King Faisal Specialist Hospital and Research Centre
record_format Article
series Annals of Saudi Medicine
spelling doaj.art-90c55459f0644dba81d61e4bb514b3692022-12-22T01:49:45ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662016-01-01361172210.5144/0256-4947.2016.17asm-1-17Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)Akram Saleh0Ayman Hammoudeh1Ramzi Tabbalat2Imadd Al-haddad3Eyass Al-Mousa4Mohammad Jarrah5Mahmoud Izraiq6Assem Nammas7Husham Janabi8Lewa Hazaymeh9Ali Shakhatreh10Youssef Khadder11From the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the Cardiology Department, Istishari Hospital, Amman, JordanFrom the Cardiology Department, Alkhalidi Hospital, Amman, JordanFrom the Cardiology Department, Jordan Hospital, Amman, JordanFrom the Cardiology Department, Istishari Hospital, Amman, JordanFrom the Cardiology Department, King Abdullah University Hospital, Irbid, JordanFrom the Cardiology Department, Ibn Alyaythem Hospital, Amman, JordanFrom the Cardiology Department, Ibn Alyaythem Hospital, Amman, JordanFrom the Cardiology Department, Prince Hamzeh Hospital, Amman, JordanFrom the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the School of Medicine, Jordan University of Science and Technology-Family Medicine, University of Jordan, Irbid, JordanBACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective multicenter registry of consecutive patients who underwent PCI between January 2013 and February 2014 (JoPCR1). SETTING: 12 tertiary care centers in Amman and Irbid, Jordan. PATIENTS AND METHODS: We collected clinical baseline and follow-up data. MAIN OUTCOME MEASURES: Incidence of stent thrombosis. RESULTS: The mean (standard deviation) age of patients (n=2426) was 59.0 (10.1) years and 20.6% were women. Stents (n=3038) were drug eluting (89.6%), bare metal (9.4%) or bioabsorbable (1.0%). After 1 year, 47 patients (1.97%) had ST, including 44 (94%) definite and 3 (6%) probable ST. Patients who had ST presented with sudden death (n=6; 12.2%) or with a nonfatal event (n=43; 87.8%). Nonfatal events included non-ST-segment elevation acute coronary syndrome (26; 53%), acute ST segment elevation myocardial infarction (n=15; 31%) or heart failure (n=2; 4.1%). ST was associated with significantly higher one-month (22.0% vs. 0.7%) and one-year (12.3% vs. 0.73%) mortality rates compared with patients who did not have ST (P<;.001). ST patients were younger (mean age 52.9 years vs. 58.4 years), had heart failure (64% vs. 18%), left ventricular ejection fraction (LVEF) <45% (36% vs. 13%), ST-segment deviation (70% vs. 48%), and elevated cardiac biomarkers blood levels (62% vs. 40%). In the multivariate analysis, the only factor that was significantly associated with ST was the heart failure (OR = 3.5, 95% confidence interval: 1.8, 6.6; P<.0001). CONCLUSIONS: The incidence of ST was not different from that in other regions and was associated with an increased one-year mortality. Younger age, heart failure, low LVEF, ST-segment deviation, and elevated blood levels of cardiac biomarkers were predictors of ST. LIMITATIONS: Possible selection bias, recall bias, and missing or incomplete information. The majority of patients were lost to follow up after the 6th month. The registry may not fully represent PCI practice and outcome in all areas in the country or region.https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17
spellingShingle Akram Saleh
Ayman Hammoudeh
Ramzi Tabbalat
Imadd Al-haddad
Eyass Al-Mousa
Mohammad Jarrah
Mahmoud Izraiq
Assem Nammas
Husham Janabi
Lewa Hazaymeh
Ali Shakhatreh
Youssef Khadder
Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
Annals of Saudi Medicine
title Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
title_full Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
title_fullStr Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
title_full_unstemmed Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
title_short Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
title_sort incidence and prognosis of stent thrombosis following percutaneous coronary intervention in middle eastern patients the first jordanian percutaneous coronary intervention registry jopcr1
url https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17
work_keys_str_mv AT akramsaleh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT aymanhammoudeh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT ramzitabbalat incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT imaddalhaddad incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT eyassalmousa incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT mohammadjarrah incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT mahmoudizraiq incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT assemnammas incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT hushamjanabi incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT lewahazaymeh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT alishakhatreh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1
AT youssefkhadder incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1